Concepedia

Stefania Marcenaro

SM

Statistics

Publications

17

Citations

3.7K

H-Index

16

Active since

2001

Affiliations

Istituto Giannina Gaslini(Current)

University of Genoa

Alleanza Contro il Cancro

Ospedale Policlinico San Martino

Meyer Children's Hospital

Stefania Marcenaro is an author at Istituto Giannina Gaslini specializing in life sciences, immunology, and natural killer cell biology.

ORCID

Publications per year

2001–2017

17

Publications

17

Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

Cristina Bottino, Roberta Castriconi, Daniela Pende et al. · The Journal of Experimental Medicine · 2003 · 843 citations · Full text

, , +17

Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.

Daniela Pende, Paola Rivera, Stefania Marcenaro et al. · PubMed · 2002 · 504 citations

, , +17

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

Daniela Pende, Stefania Marcenaro, Michela Falco et al. · Blood · 2008 · 370 citations · Full text

, , +15

Analysis of the receptor-ligand interactions in the natural killer–mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)

Daniela Pende, Grazia Maria Spaggiari, Stefania Marcenaro et al. · Blood · 2004 · 360 citations

, , +17

Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin

Daniela Pende, Claudia Cantoni, Paola Rivera et al. · European Journal of Immunology · 2001 · 322 citations · Full text

, , +13

1–5 of 17